Market Exclusive

Analyst Upgrades – Diplomat Pharmacy (NYSE:DPLO) Stock Gets Upgraded By Credit Suisse Group from Underperform to Neutral

Analyst Ratings For Diplomat Pharmacy (NYSE:DPLO)

Today, Diplomat Pharmacy (NYSE:DPLO) stock received an upgrade by Credit Suisse Group from Underperform to Neutral.

Some recent analyst ratings include

Recent Insider Trading Activity For Diplomat Pharmacy (NYSE:DPLO)
Diplomat Pharmacy (NYSE:DPLO) has insider ownership of 30.20% and institutional ownership of 72.45%.

Recent Trading Activity for Diplomat Pharmacy (NYSE:DPLO)
Shares of Diplomat Pharmacy closed the previous trading session at 26.10 up +0.21 0.81% with 138836 shares trading hands.

Exit mobile version